Lyme Disease - Pipeline Review, H1 Market Supply-Demand, Industry Research and End User Analysis to 2017
Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Lyme Disease - Pipeline Review, H1 2017, provides an overview of the Lyme Disease (Infectious Disease) pipeline landscape. Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches and headache. Risk factors include age, gender and geographic locations. Treatment includes antibiotics. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Lyme Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Lyme Disease (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development histo...